Inactive Instrument

MEDH ACQU Stock

MTAC

US58507N1054

MedTech Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses primarily operating in the healthcare sector in the United States. The Company has not commenced any business operations and has not generated any revenue.

Sector

More about the company

MedTech Acquisition, TriSalus Life Sciences Complete Merger	23-08-10	MT
MedTech Acquisition Corporation(NasdaqCM:MTAC) dropped from NASDAQ Composite Index	23-08-10	CI
Trisalus Life Sciences Inc. completed the acquisition of MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others.	23-08-09	CI
Top Premarket Gainers	23-08-08	MT
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
MedTech Acquisition Corporation announced that it has received $0.137375 million in funding	23-06-14	CI
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases At the Asco 2023 Annual Meeting	23-06-12	CI
MedTech Acquisition Corporation announced that it expects to receive $17.85502 million in funding	23-06-06	CI
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
MedTech Acquisition Corporation Auditor Raises 'Going Concern' Doubt	23-03-21	CI
Magnetar Capital Engages in Discussions with MedTech Acquisition Corporation	23-02-09	CI
MedTech Acquisition Corporation announced that it has received $1.468821 million in funding from Medtech Acquisition Sponsor LLC	22-12-15	CI
TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncologyâ„¢ (PERIOâ„¢) Clinical Trial Progress and Pre-clinical Research Developments	22-12-15	CI
TriSalus Life Sciences to Merge With MedTech Acquisition to Go Public	22-11-14	MT
Trisalus Life Sciences Inc. entered into a definitive merger agreement to acquire MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others for $220 million in a reverse merger transaction.	22-11-13	CI

MEDH ACQU : STANDBY EQUITY PURCHASE AGREEMENT - Form 8-K	23-10-03	PU
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders	23-08-02	BU
MedTech Acquisition : Material Event - Form 8-K	23-08-02	PU
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-06-15	AQ
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD Method with the TriNav Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting	23-06-13	AQ

MEDH ACQU Stock

Equities

MTAC

US58507N1054

Chart MEDH ACQU

Latest news about MEDH ACQU

Press releases MEDH ACQU

ETFs positioned on MEDH ACQU

Company Profile